| Literature DB >> 29904353 |
Tomasz Walski1,2, Anna Drohomirecka2,3, Jolanta Bujok2,4, Albert Czerski2,4, Grzegorz Wąż2,5, Natalia Trochanowska-Pauk1,2, Michał Gorczykowski6, Romuald Cichoń5, Małgorzata Komorowska1,2.
Abstract
Aim: An activation of non-specific inflammatory response, coagulation disorder, and blood morphotic elements damage are the main side effects of the extracorporeal circulation (ECC). Red-to-near-infrared radiation (R/NIR) is thought to be capable of stabilizing red blood cell (RBC) membrane through increasing its resistance to destructive factors. We focused on the development of a method using low-level light therapy (LLLT) in the spectral range of R/NIR which could reduce blood trauma caused by the heart-lung machine during surgery.Entities:
Keywords: cardiopulmonary bypass (CPB); extracorporeal circulation (ECC); heart-lung machine; hemolysis; low-level light therapy (LLLT); near-infrared radiation (NIR); photobiomodulation; red blood cell
Year: 2018 PMID: 29904353 PMCID: PMC5991292 DOI: 10.3389/fphys.2018.00647
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Hematological and biochemical parameters assessed during entire experimental period.
| Parameter | Group | T0 | T0.5 | T1 | T6 | T12 | T24 | Reference ranges | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | Mean | Mean | Mean | Mean | Mean | |||||||||
| RBC count | CTR | 6.02 | 0.49 | 5.49 | 0.43 | 5.78 | 0.63 | 6.06 | 0.83 | 5.53 | 0.91 | 5.05 | 0.85 | 5.00 ÷ 8.00 |
| (× 1012/L) | NIR | 5.60 | 0.41 | 4.99< | 0.60 | 5.51 | 0.56 | 5.02 | 0.61 | 4.77< | 0.72 | 4.54< | 0.84 | |
| Hgb | CTR | 119 | 11 | 107 | 11 | 113 | 12 | 120 | 16 | 107 | 17 | 97 | 16 | 100 ÷ 160 |
| (g/L) | NIR | 111 | 9 | 97< | 10 | 108 | 13 | 100 | 13 | 94< | 15 | 90< | 16 | |
| PFHgb | CTR | 1.89 | 0.49 | 1.30 | 0.43 | 1.81 | 0.41 | 1.67 | 0.54 | 1.31 | 0.35 | 1.58 | 0.35 | 0.81 ÷ 2.9a |
| (mg/L) | NIR | 1.83 | 0.50 | 0.96 | 0.29 | 1.33 | 0.43 | 1.04 | 0.34 | 0.95 | 0.34 | 1.17 | 0.47 | |
| Bilirubin | CTR | 4.25 | 1.90 | – | – | 5.47 | 1.90 | 3.83 | 1.51 | 4.22 | 2.61 | 3.36 | 1.00 | 0.00 ÷ 17.10 |
| (μmol/L) | NIR | 4.39 | 1.50 | 3.66 | 1.18 | 3.25 | 0.92 | 2.99 | 1.26 | 3.72 | 1.23 | |||
| Haptoglobin | CTR | 0.49 | 0.50 | 0.31< | 0.42 | 0.31< | 0.37 | 0.29< | 0.42 | 0.35< | 0.35 | 1.01 | 0.23 | 0.37 ÷ 0.69a |
| (g/L) | NIR | 0.57 | 0.49 | 0.44 | 0.46 | 0.37 | 0.44 | 0.38 | 0.42 | 0.61 | 0.41 | 1.26 | 0.16 | |
| LDH | CTR | 421 | 159 | 407 | 153 | 481 | 155 | 872> | 370 | 735> | 404 | 931> | 840 | 380 ÷ 634 |
| (U/L) | NIR | 526 | 73 | 435 | 98 | 560 | 127 | 616 | 180 | 608 | 117 | 524 | 89 | |
| WBC count | CTR | 16.02 | 4.63 | 12.54 | 5.66 | 14.13 | 6.82 | 22.38> | 5.29 | 19.43 | 5.76 | 16.54 | 4.75 | 11.0 ÷ 22.0 |
| (× 109/L) | NIR | 18.63 | 5.21 | 16.38 | 7.16 | 16.60 | 6.25 | 21.66 | 5.68 | 20.30 | 5.25 | 15.56 | 5.60 | |
| TBARS | CTR | 11.80 | 1.73 | 14.48 | 2.94 | 14.14 | 2.60 | 17.01> | 7.68 | 16.01> | 7.68 | 15.78> | 6.01 | 7.79 ÷ 15.72a |
| (nmol/gHgb) | NIR | 11.72 | 2.02 | 12.28 | 2.26 | 10.58 | 1.47 | 14.31 | 3.51 | 14.58 | 3.42 | 13.42 | 3.63 | |
| TAC | CTR | 1.60 | 0.06 | 1.37 | 0.08 | 1.50 | 0.09 | 1.53 | 0.09 | 1.61 | 0.12 | 1.60 | 0.08 | 1.40 ÷ 1.77a |
| (mmol Trolox eq./L) | NIR | 1.57 | 0.11 | 1.39 | 0.11 | 1.48 | 0.12 | 1.56 | 0.15 | 1.58 | 0.11 | 1.61 | 0.11 | |